Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs

被引:33
|
作者
Pericas, Juan M. [1 ]
Llopis, Jaume [1 ,2 ]
Athan, Eugene [3 ,4 ]
Hernandez-Meneses, Marta [1 ]
Hannan, Margaret M. [5 ]
Murdoch, David R. [6 ]
Kanafani, Zeina [7 ]
Freiberger, Tomas [8 ,9 ]
Strahilevitz, Jacob [10 ]
Fernandez-Hidalgo, Nuria [11 ]
Lamas, Cristiane [12 ]
Durante-Mangoni, Emanuele [13 ]
Tattevin, Pierre [14 ]
Nacinovich, Francisco [15 ]
Chu, Vivian H. [16 ]
Miro, Jose M. [1 ]
机构
[1] Univ Barcelona, Hosp Clin IDIBAPS, Infect Dis Dept, Barcelona, Spain
[2] Univ Barcelona, Dept Genet Microbiol & Stat, Barcelona, Spain
[3] Barwon Health, Dept Infect Dis, Geelong, Vic, Australia
[4] Deakin Univ, Geelong, Vic, Australia
[5] Mater Misericordiae Univ Hosp, Dept Microbiol, Dublin, Ireland
[6] Univ Otago, Dept Pathol & Biomed Sci, Christchurch, New Zealand
[7] Amer Univ Beirut, Div Infect Dis, Beirut, Lebanon
[8] Ctr Cardiovasc Surg & Transplantat, Brno, Czech Republic
[9] Masaryk Univ, Fac Med, Brno, Czech Republic
[10] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[11] Univ Autonoma Barcelona, Serv Malalties Infeccioses, Hosp Univ Vall dHebron, Barcelona, Spain
[12] Inst Nacl Cardiol & Unigranrio, Rio De Janeiro, Brazil
[13] Univ Campania, Monaldi Hosp, Internal Med, Naples, Italy
[14] Pontchaillou Univ Hosp, Infect Dis & Intens Care Unit, Rennes, France
[15] Inst Cardiovasc Buenos Aires, Buenos Aires, DF, Argentina
[16] Duke Univ, Sch Med, Durham, NC USA
关键词
cardiac surgery; HIV; infective endocarditis; opioid crisis; people who inject drugs; Staphylococcus aureus; INTERNATIONAL COLLABORATION; CLINICAL PRESENTATION; EPIDEMIOLOGY; ETIOLOGY;
D O I
10.1016/j.jacc.2020.11.062
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Infective endocarditis (IE) in people who inject drugs (PWID) is an emergent public health problem. OBJECTIVES The purpose of this study was to investigate IE in PWID and compare it with IE in non-PWID patients. METHODS Two prospective cohort studies (ICE-PCS and ICE-Plus databases, encompassing 8,112 IE episodes from 2000 to 2006 and 2008 to 2012, with 64 and 34 sites and 28 and 18 countries, respectively). Outcomes were compared between PWID and non-PWID patients with IE. Logistic regression analyses were performed to investigate risk factors for 6-month mortality and relapses amongst PWID. RESULTS A total of 7,616 patients (591 PWID and 7,025 non-PWID) were included. PWID patients were significantly younger (median 37.0 years [interquartile range: 29.5 to 44.2 years] vs. 63.3 years [interquartile range: 49.3 to 74.0 years]; p < 0.001), male (72.5% vs. 67.4%; p = 0.007), and presented lower rates of comorbidities except for human immunodeficiency virus, liver disease, and higher rates of prior IE. Amongst IE cases in PWID, 313 (53%) episodes involved left-side valves and 204 (34.5%) were purely left-sided IE. PWID presented a larger proportion of native IE (90.2% vs. 64.4%; p < 0.001), whereas prosthetic-IE and cardiovascular implantable electronic device-IE were more frequent in non-PWID (9.3% vs. 27.0% and 0.5% vs. 8.6%; both p < 0.001). Staphylococcus aureus caused 65.9% and 26.8% of cases in PWID and non-PWID, respectively (p < 0.001). PWID presented higher rates of systemic emboli (51.1% vs. 22.5%; p < 0.001) and persistent bacteremia (14.7% vs. 9.3%; p < 0.001). Cardiac surgery was less frequently performed (39.5% vs. 47.8%; p < 0.001), and in-hospital and 6-month mortality were lower in PWID (10.8% vs. 18.2% and 14.4% vs. 22.2%; both p < 0.001), whereas relapses were more frequent in PWID (9.5% vs. 2.8%; p < 0.001). Prior IE, left-sided IE, polymicrobial etiology, intracardiac complications, and stroke were risk factors for 6-month mortality, whereas cardiac surgery was associated with lower mortality in the PWID population. CONCLUSIONS A notable proportion of cases in PWID involve left-sided valves, prosthetic valves, or are caused by microorganisms other than S. aureus. (C) 2021 by the American College of Cardiology Foundation.
引用
收藏
页码:544 / 555
页数:12
相关论文
共 50 条
  • [31] Peripherally Inserted Central Catheter Line Misuse Among People Who Inject Drugs While on Therapy for Infective Endocarditis
    Adams, Janica
    Elton-Marshall, Tara
    Shojaei, Esfandiar
    Silverman, Michael
    [J]. AMERICAN JOURNAL OF MEDICINE, 2022, 135 (09): : E324 - E336
  • [32] Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis
    David Goodman-Meza
    Robert E. Weiss
    Sebastián Gamboa
    Abel Gallegos
    Alex A. T. Bui
    Matthew B. Goetz
    Steven Shoptaw
    Raphael J. Landovitz
    [J]. BMC Infectious Diseases, 19
  • [33] PHARMACEUTICAL OPIOID USE AND PAIN AMONG PEOPLE WHO INJECT DRUGS: BASELINE FINDINGS FROM A PROSPECTIVE COHORT STUDY
    Larance, Briony
    Nielsen, Suzanne
    Hordern, Antonia
    Lintzeris, Nicholas
    Burns, Lucinda
    Mattick, Richard
    Campbell, Gabrielle
    Farrell, Michael
    Cohen, Milton
    Bruno, Raimondo
    Brown, Amanda
    Johnson, Jennifer
    Degenhardt, Louisa
    [J]. DRUG AND ALCOHOL REVIEW, 2014, 33 : 6 - 6
  • [34] Reply to: impact of Chronic Hepatitis C virus co-infection on outcomes of infective endocarditis in people who inject drugs
    De Benedetto, Ilaria
    Boglione, Lucio
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2022, 102 (03)
  • [35] Correlates of 90-Day Mortality Among People Who Do and Do Not Inject Drugs With Infective Endocarditis in Seattle, Washington
    Corcorran, Maria A.
    Stewart, Jenell
    Lan, Kristine
    Gupta, Ayushi
    Glick, Sara N.
    Seshadri, Chetan
    Koomalsingh, Kevin J.
    Gibbons, Edward F.
    Harrington, Robert D.
    Dhanireddy, Shireesha
    Kim, H. Nina
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (05):
  • [36] Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs
    Wurcel, Alysse G.
    Anderson, Jordan E.
    Chui, Kenneth K. H.
    Skinner, Sally
    Knox, Tamsin A.
    Snydman, David R.
    Stopka, Thomas J.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (03):
  • [37] Experiences of participation in a longitudinal cohort study of people who inject drugs in Victoria, Australia
    Berryman, Bebe
    Niesen, Rachel
    Higgs, Peter
    Dietze, Paul
    Stewart, Ashleigh
    Cossar, Reece
    Walker, Shelley
    [J]. DRUGS-EDUCATION PREVENTION AND POLICY, 2024, 31 (02) : 229 - 238
  • [38] A Wake-Up Call: Outcomes Following Infective Endocarditis in Persons Who Inject Drugs
    Schranz, Asher J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (03) : 572 - 573
  • [39] Recurrent Endocarditis in Persons Who Inject Drugs
    Rodger, Laura
    Shah, Meera
    Shojaei, Esfandiar
    Hosseini, Seyed
    Koivu, Sharon
    Silverman, Michael
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (10):
  • [40] Brucella Endocarditis in Persons Who Inject Drugs
    Cafardi, John M.
    Haas, Douglas
    Lamarre, Thomas
    Feinberg, Judith
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (04):